Africa CDC calls for urgent funding and homegrown vaccines as Ebola outbreak spreads
Africa CDC urges immediate increased funding and vaccine development to tackle the Ebola outbreak in the Democratic Republic of Congo and Uganda and reduce reliance on foreign aid.
Africa’s public health agency has warned that the current Ebola outbreak, now affecting communities in the Democratic Republic of Congo and Uganda, requires urgent increases in African financing and accelerated development of regionally appropriate vaccines. Dr. Jean Kaseya, director general of the Africa Centres for Disease Control and Prevention, described the spread as the most severe to date at this stage and urged member states and regional partners to scale up investment in surveillance, laboratory capacity and vaccine research. The call reflects growing concern that repeated reliance on external partners leaves the continent vulnerable to delayed responses and supply gaps during high-risk epidemics.
Africa CDC warns the outbreak is worsening
Dr. Jean Kaseya told officials and public health experts that the Ebola outbreak’s trajectory highlights gaps in preparedness across multiple countries. He said Africa cannot continue to depend primarily on foreign donors and manufacturers for essential medical countermeasures, including vaccines and therapeutics. The agency emphasized that rapid escalation of local funding would shorten response times and improve case detection, contact tracing and community engagement in affected areas. Officials framed the current situation as a strategic inflection point for Africa’s long-term health security.
Short-term needs: funding, vaccines and logistics
Experts working with national ministries say immediate priorities include boosting emergency funding, expanding cold-chain logistics and accelerating vaccine deployment where appropriate. Several respondents noted that financing shortfalls impede procurement and distribution of vaccines and personal protective equipment to remote and border communities. Strengthening logistics chains and establishing regional vaccine stockpiles could reduce lead times and help contain outbreaks before they cross borders. Donors and governments were urged to prioritize flexible emergency funds that can be rapidly deployed as cases emerge.
Medium-term investments in manufacturing and research
Africa CDC and allied institutions have renewed calls for the continent to invest in local vaccine research and manufacturing capacity to reduce dependence on overseas producers. Building regional production hubs, training biomedical personnel and supporting clinical trial networks would allow Africa to generate and adapt vaccines tailored to local needs. Such investment would also support regulatory frameworks, quality control and supply chains needed for sustainable vaccine manufacturing. Authorities said that medium-term domestic industry development is essential to close the gap between outbreak onset and vaccine availability.
Strengthening surveillance and workforce capacity
Public health leaders stressed that improved surveillance, laboratory networks and a trained outbreak workforce are critical to detect and respond to Ebola outbreaks earlier. Expanded genomic surveillance and faster laboratory confirmation can inform targeted interventions and control measures. Training programs to scale up community health workers, epidemic response teams and risk-communication specialists will be necessary to maintain readiness. Cross-border surveillance agreements and data-sharing mechanisms were recommended to coordinate responses across the DRC, Uganda and neighboring countries.
Community engagement and risk communication
Officials highlighted that community trust remains a decisive factor in containing Ebola outbreaks, and that risk communication must be culturally informed and sustained. Effective engagement with local leaders, religious figures and community health volunteers can improve reporting of suspected cases and adherence to infection prevention measures. Messaging that addresses vaccine hesitancy and misinformation is also a priority, particularly where past outbreaks have eroded public trust. Investments in community-based approaches were presented as cost-effective measures that amplify clinical response efforts.
The Africa CDC’s appeal urges governments, regional bodies and development partners to treat the current Ebola outbreak as a catalyst for a broader shift in how the continent funds and prepares for epidemics. By accelerating both immediate support and longer-term investments in vaccine development, manufacturing and surveillance, African nations can reduce the lag between outbreak detection and response. The agency framed these measures as essential not only to manage the current crisis in the Democratic Republic of Congo and Uganda, but to strengthen resilience against future public health emergencies.
